Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis.

MLA

Romani, Luigina, et al. “Thymosin Α1 Represents a Potential Potent Single-Molecule-Based Therapy for Cystic Fibrosis.” Nature Medicine, vol. 23, no. 5, May 2017, pp. 590–600. EBSCOhost, https://doi.org/10.1038/nm.4305.

APA

Romani, L., Oikonomou, V., Moretti, S., Iannitti, R. G., D’Adamo, M. C., Villella, V. R., Pariano, M., Sforna, L., Borghi, M., Bellet, M. M., Fallarino, F., Pallotta, M. T., Servillo, G., Ferrari, E., Puccetti, P., Kroemer, G., Pessia, M., Maiuri, L., Goldstein, A. L., & Garaci, E. (2017). Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis. Nature Medicine, 23(5), 590–600. https://doi.org/10.1038/nm.4305

Chicago

Romani, Luigina, Vasilis Oikonomou, Silvia Moretti, Rossana G Iannitti, Maria Cristina D’Adamo, Valeria R Villella, Marilena Pariano, et al. 2017. “Thymosin Α1 Represents a Potential Potent Single-Molecule-Based Therapy for Cystic Fibrosis.” Nature Medicine 23 (5): 590–600. doi:10.1038/nm.4305.